In one large clinical trial sponsored by Novo Nordisk, 1,961 adults with excess weight or obesity who did not have diabetes were given 2.4 milligrams of semaglutide or a placebo once a week for 68 weeks, along with lifestyle intervention. Those who took semaglutide lost 14.9% of their body weight compared with 2.4% for those who took the placebo.
https://www.forbes.com/health/body/ozempic-for-weight-loss/
So for a 150kg person, 15% weight loss makes them a 128kg person - still obese after 68 weeks. And ive read the injection is around $1000 per month ($12000 per year). Its not so effective to completely cure obesity, it just helps and an aid to weight loss. Its not going to have such a drastic effect on sleep apnea and other obesity related respiratory issues as the market is predicting (IMO).
GLP-1 and OSA, page-28
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.46 |
Change
-0.690(1.81%) |
Mkt cap ! $23.02B | |||
| Open | High | Low | Value | Volume |
| $37.62 | $37.82 | $37.42 | $6.458M | 171.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 875 | $37.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.46 | 1215 | 11 |
View Market Depth
| Last trade - 12.28pm 13/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |